# Jubilant HollisterStier General Partnership - Inspection Records

Source: https://www.keypedia.com/companies/jubilant-hollisterstier-general-partnership/fd593d8a-dc2a-4d60-b14d-bbb95e4c0011

> Inspection records and compliance data for Jubilant HollisterStier General Partnership in Quebec, H9H. Access full analysis and detailed observations.

---

## Details

- Name: Jubilant HollisterStier General Partnership
- FEI Number: 3001623073
- City: Quebec
- State: H9H
- Country Name: Canada
- Address Line 1: 16751 Rte Transcanadienne
- Address Line 2: Kirkland
- Zip Code: 4J4
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Jubilant HollisterStier General Partnership - 2025-11-03](https://www.keypedia.com/records/483/jubilant-hollisterstier-general-partnership/2769eb91-40eb-43ba-bb67-bbe38104b6ea) — source: FDA, date: November 3, 2025
- [FDA Inspection 1289886 - Jubilant HollisterStier General Partnership - 2025-11-03](https://www.keypedia.com/records/fda_inspections/jubilant-hollisterstier-general-partnership/03fb1c6f-46c2-463e-9c61-6ed29688daf1) — classification: Official Action Indicated (OAI), source: FDA, date: November 3, 2025
- [FDA Inspection 1289886 - Jubilant HollisterStier General Partnership - 2025-11-03](https://www.keypedia.com/records/fda_inspections/jubilant-hollisterstier-general-partnership/c7bc60d3-d5f8-4b4e-ac62-9a1d1019ea3c) — classification: Official Action Indicated (OAI), source: FDA, date: November 3, 2025
- [FDA Inspection 1289886 - Jubilant HollisterStier General Partnership - 2025-11-03](https://www.keypedia.com/records/fda_inspections/jubilant-hollisterstier-general-partnership/ddba8f53-8399-4fdc-ba6f-6fa3341031e1) — source: FDA, date: November 3, 2025
- [FDA Inspection 1289886 - Jubilant HollisterStier General Partnership - 2025-11-03](https://www.keypedia.com/records/fda_inspections/jubilant-hollisterstier-general-partnership/0a609c97-e281-44e0-928c-dd3c66e6834a) — classification: Official Action Indicated (OAI), source: FDA, date: November 3, 2025
- [483 - Jubilant HollisterStier General Partnership - 2024-06-14](https://www.keypedia.com/records/483/jubilant-hollisterstier-general-partnership/e9b167e3-9b61-452c-9c8b-ad02c007f690) — source: FDA, date: June 14, 2024
- [483 - Jubilant HollisterStier General Partnership - 2024-06-14](https://www.keypedia.com/records/483/jubilant-hollisterstier-general-partnership/befabb74-9df6-4162-908b-bc413310e749) — source: FDA, date: June 14, 2024
- [FDA Inspection 1242347 - Jubilant HollisterStier General Partnership - 2024-06-14](https://www.keypedia.com/records/fda_inspections/jubilant-hollisterstier-general-partnership/026f5cb8-d0e0-4303-b6a5-d07ce483cb20) — classification: Official Action Indicated (OAI), source: FDA, date: June 14, 2024
- [FDA Inspection 1242347 - Jubilant HollisterStier General Partnership - 2024-06-14](https://www.keypedia.com/records/fda_inspections/jubilant-hollisterstier-general-partnership/11f27799-0652-4128-a5b0-54a5bdd42527) — classification: Official Action Indicated (OAI), source: FDA, date: June 14, 2024
- [Canada Inspection - Jubilant HollisterStier General Partnership - Inspection #82684 - 2024-01-22](https://www.keypedia.com/records/canada_inspection/jubilant-hollisterstier-general-partnership/5a3a865e-5a09-48b9-9f47-24c1e0960626) — source: Canada, date: January 22, 2024
- [483 - Jubilant HollisterStier General Partnership - 2023-02-28](https://www.keypedia.com/records/483/jubilant-hollisterstier-general-partnership/f3b980c5-7eb1-4481-9eff-7a8d0e6dfe67) — source: FDA, date: February 28, 2023
- [EIR - Jubilant HollisterStier General Partnership - 2023-02-28](https://www.keypedia.com/records/eir/jubilant-hollisterstier-general-partnership/1937548f-0fee-482d-844a-a4acc7d679b1) — source: FDA, date: February 28, 2023
- [483 - Jubilant HollisterStier General Partnership - 2023-02-28](https://www.keypedia.com/records/483/jubilant-hollisterstier-general-partnership/8627a3ac-4abd-4b42-a938-ad8ce52d6b8e) — source: FDA, date: February 28, 2023
- [FDA Inspection 1181741 - Jubilant HollisterStier General Partnership - 2022-10-07](https://www.keypedia.com/records/fda_inspections/jubilant-hollisterstier-general-partnership/434d0b30-4fa0-48ec-b2f7-be7283302ac3) — classification: No Action Indicated (NAI), source: FDA, date: October 7, 2022
- [Canada Inspection - Jubilant HollisterStier General Partnership - Inspection #77384 - 2021-10-12](https://www.keypedia.com/records/canada_inspection/jubilant-hollisterstier-general-partnership/7e4b230d-1a0d-41bd-bc80-3716ce06916c) — source: Canada, date: October 12, 2021
- [Canada Inspection - Jubilant HollisterStier General Partnership - Inspection #73266 - 2019-12-04](https://www.keypedia.com/records/canada_inspection/jubilant-hollisterstier-general-partnership/e429899c-4aa4-4927-abc6-6d4d5c3ef709) — source: Canada, date: December 4, 2019
- [483 - Jubilant HollisterStier General Partnership - 2018-06-01](https://www.keypedia.com/records/483/jubilant-hollisterstier-general-partnership/614c1fb7-5a4f-4731-9eeb-c77885572e9d) — source: FDA, date: June 1, 2018
- [FDA Inspection 1054645 - Jubilant HollisterStier General Partnership - 2018-06-01](https://www.keypedia.com/records/fda_inspections/jubilant-hollisterstier-general-partnership/f923c34a-24ff-4825-ac3c-25d24709e0a4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2018
- [FDA Inspection 1054645 - Jubilant HollisterStier General Partnership - 2018-06-01](https://www.keypedia.com/records/fda_inspections/jubilant-hollisterstier-general-partnership/4089c9bc-ef59-4f0a-8a37-b46afa921131) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2018
- [Canada Inspection - Jubilant HollisterStier General Partnership - Inspection #68551 - 2017-10-23](https://www.keypedia.com/records/canada_inspection/jubilant-hollisterstier-general-partnership/5da165b6-7ee7-4cf9-9bae-e0f1eae55478) — source: Canada, date: October 23, 2017

## Related Companies

- [Resilience Biotechnologies, Inc.](https://www.keypedia.com/companies/resilience-biotechnologies-inc/b3d6ed53-42d5-4c02-adca-c777bb39151c)
- [E-Z-EM Canada, Inc](https://www.keypedia.com/companies/e-z-em-canada-inc/de31e064-9679-4127-b65f-39ecba03c801)
- [Viva Pharmaceutical Inc](https://www.keypedia.com/companies/viva-pharmaceutical-inc/0e5d1aa3-8369-4a0d-91b7-e516415fb219)
- [Groupe Parima Inc.](https://www.keypedia.com/companies/groupe-parima-inc/49e213ea-3ec6-4535-adaf-c0b6c7d25a23)
- [Kenvue Canada Inc.](https://www.keypedia.com/companies/kenvue-canada-inc/5ebdb680-6bdf-4d05-887c-3d175e32f038)
- [Confab Laboratories Inc.](https://www.keypedia.com/companies/confab-laboratories-inc/cae88900-5d2c-47b7-aedc-3931dd4f8310)
- [Catalent Ontario Limited](https://www.keypedia.com/companies/catalent-ontario-limited/d28dfd20-1d16-4261-94e1-77497eb5150c)
- [Vetio Animal Health](https://www.keypedia.com/companies/vetio-animal-health/7b019ca7-7830-408c-a1f0-bc4a533fd9a4)
- [Cosmetica Laboratories Inc.](https://www.keypedia.com/companies/cosmetica-laboratories-inc/bcfa9f67-ec98-41ed-a67f-62ff5060c0be)
- [Emergent BioSolutions Canada Inc.](https://www.keypedia.com/companies/emergent-biosolutions-canada-inc/b307e34c-3470-4633-86ab-237341dae46c)

## Related Officers

- [company_representative](https://www.keypedia.com/people/christopher-s-preti/006be8b5-7c26-4723-a837-38fab8e617a6)
- [other](https://www.keypedia.com/people/steven-p-eastham/3019e20c-8828-48f4-8e72-8fcb0636a660)
- [Investigator ](https://www.keypedia.com/people/logan-t-williams/a1febf59-970a-4e4e-9c0c-f4ad385582d7)
- [Investigator](https://www.keypedia.com/people/rafeeq-a-habeeb/ac58c0b7-bd42-4037-8ccb-bf0351b7744f)
- [Investigator](https://www.keypedia.com/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)
- [Consumer Safety Officer](https://www.keypedia.com/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3)